Deal type
Capital Markets & IPO
1,925 announced Capital Markets & IPO deals, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 1,925 Sidley Represents Initial Purchasers in MidCap Financial’s US$500 Million Senior Notes Offering 11 Nov 2026
Latham Advises on SmartStop Self Storage REIT’s Upsized Public Offering of Common Stock 11 Nov 2026
Latham & Watkins Represents Janus Living in Upsized US$860.34 Million Public Offering 11 Nov 2026
Linklaters advises on EAAA India Alternatives’ INR 12bn IPO in India 11 Nov 2026
Herbert Smith Freehills Kramer advises joint sponsors and underwriters of Denglin Technology on its Hong Kong IPO 10 Nov 2026
Sidley Advises GPGPU Provider Denglin Technology on Its Chapter 18C Listing in Hong Kong 10 Nov 2026
Latham & Watkins Advises on Orchestra BioMed’s US$75 Million Public Offering 9 Nov 2026
Linklaters advises The Hong Kong Mortgage Corporation Limited on its fourth infrastructure loan-backed securities issuance in Hong Kong SAR 9 Nov 2026
Dentons advises Electrica on the establishment of its €1 billion bond issuance programme 6 Nov 2026
Latham Advises on Lyell Immunopharma’s US$80 Million Private Placement 6 Nov 2026
Latham & Watkins Advises Precision BioSciences on US$125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants 6 Nov 2026
Linklaters advises Rhône Group portfolio company MAXAM on €175 million high-yield tap issuance 6 Nov 2026
Linklaters advises on Persistent Systems’ INR 42.65bn qualified institutional placement of shares in India 6 Nov 2026
Sidley Represents Essential Properties in US$517.5 Million Senior Notes Offering 5 Nov 2026
Baker McKenzie Advises Banque du Caire and Banque Misr on Landmark IPO 5 Nov 2026
Dentons has advised Ignitis Group on the re-establishment of its Euro Medium Term Note Programme and a related capital markets transaction 5 Nov 2026
Clifford Chance advises the European Stability Mechanism on benchmark €1 billion digitally native notes issuance 5 Nov 2026
Clifford Chance advises joint global coordinators on Eurocommercial’s €128.4 million capital increase 5 Nov 2026
Linklaters advises on Bonfiglioli Transmissions’ INR 25.34bn IPO in India 5 Nov 2026
Sidley Advises on Southwest Airlines’ US$1.25 Billion Senior Notes Offering 3 Nov 2026
Dentons advises Vancity on two capital markets transactions totalling CA$550 million 3 Nov 2026
Hogan Lovells Cadwalader advises DZ BANK on base prospectus for crypto securities 3 Nov 2026
Clifford Chance advises on Eurasian Development Bank’s debut Dim Sum bond 3 Nov 2026
Latham Advises on Aspen Neuroscience’s US$140.6 Million IPO 3 Nov 2026
Latham & Watkins Advises on Bambusa Therapeutics’ Upsized US$168.9 Million IPO 3 Nov 2026
Latham Advises on Essential Properties Realty Trust, Inc.’s US$450 Million Exchangeable Senior Notes Offering 29 Oct 2026
Latham Advises Jio Platforms on INR 301,876 Million (US$3.2 Billion) IPO 29 Oct 2026
Linklaters advises thyssenkrupp on the spin-off and listing of tk accelis 29 Oct 2026
DLA Piper advises underwriters in Strive’s US$630 million preferred stock initial public offering 28 Oct 2026
DLA Piper advises AI-native specialty insurance platform Ledgebrook on primary equity financing 28 Oct 2026
DLA Piper advises Retension Pharmaceuticals on initial public offering 28 Oct 2026
Linklaters advises on Runwal Enterprises Limited’s IPO in India 28 Oct 2026
Dentons advises FAB on AED 1 billion MENA-first digitally native green bond 27 Oct 2026
Clifford Chance advises the underwriters on CAF’s US$2 billion notes offering 27 Oct 2026
Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 27 Oct 2026
Latham Advises on Corxel Pharmaceuticals and Amanat Acquisition Corp.’s Business Combination Agreement to Create a Publicly Listed Obesity-Focused Biopharmaceutical Company 27 Oct 2026
Latham Advises on Zetwerk’s US$529 Million IPO 27 Oct 2026
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Linklaters advises BOC on two landmark offshore Renminbi notes issuances in Dubai and Europe 27 Oct 2026
Linklaters advises on Adani Group company Cemindia Projects’ US$146m qualified institutional placement of shares in India 27 Oct 2026
Linklaters advises Schneider Electric on its €6bn share capital increase 27 Oct 2026
News Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 22 Oct 2026
Linklaters advises Joint Lead Managers on first benchmark DLT-native sovereign bond issuance by the Grand Duchy of Luxembourg 22 Oct 2026
Herbert Smith Freehills Kramer advises Airtel Africa plc on IPO 21 Oct 2026
Clifford Chance advises the Lao People’s Democratic Republic on US$500 million Reg S/144A bond issuance 21 Oct 2026
Latham Advises on Mynt’s ₱53 Billion IPO 21 Oct 2026
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, have announced the execution of a definitive business combination agreement that will result in TriGemX Bio becoming a publicly traded company. The combined company will be named TriGemX Bio, Inc. and is expected to trade on Nasdaq under the new ticker symbol TGEM. Latham & Watkins LLP represents TCGX in the transaction with a corporate team led by Houston partners Ryan Maierson and Ryan Lynch, with associates Taylor Allison, Cooper Shear, and Luisa Gomez Yokubaitis, with assistance from Zachary Mouton. Advice was also provided on tax matters by Houston partner Jared Grimley, with associates Dominick Constantino and Graham Core; on benefits matters by Los Angeles partner Michelle Carpenter, with associate Jordan Barnes; on healthcare regulatory matters by Washington, D.C. partner Nathan Beaton and counsel Nicole Liffrig Molife and Chad Jennings, with associate Margaret Rote; on funds matters by Chicago partner David Moore and New York partner Jennifer Tian;* on data cybersecurity matters by New York partner Jessica Cohen, with associates Laura Geraci and Nat Lewis; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen; on environmental matters by Los Angeles/Houston partner Joshua Marnitz, with associate Brandon Kerns; on anti-bribery and anti-money laundering matters by Washington, D.C. partner Daniel Dominguez, with associates Patricia Amselem Bensadon and Ai Ni Lim; on antitrust matters by Washington, D.C. partner Jason Cruise and Washington, D.C. counsel Ngoc Hulbig; and on economic sanctions and export controls matters by Washington, D.C. partner Eric Volkman, with associate Amulya Vadapalli. *Admitted to practice in Illinois only. 21 Oct 2026
Latham Advises Institutional Investors on Kapla Holding’s €100 Million Private Placement 21 Oct 2026
Linklaters advises Joint Bookrunners on DFMG Holding’s €1bn inaugural public bond issuance 21 Oct 2026
Sidley Represents Cipher Digital in US$850 Million Senior Notes Offering 19 Oct 2026
DLA Piper guides First Digital through De-SPAC business combination with KOYN 19 Oct 2026
Dentons advises Uzbekistans Tourism and Entertainment Group 19 Oct 2026
Hogan Lovells Cadwalader advises Banco Santander and UniCredit on the restructuring of ViViBanca’s CQS securitisation 19 Oct 2026
Clifford Chance advises GD Towers on its €1 billion debut public bond 19 Oct 2026
Clifford Chance advises on Transsion’s Hong Kong IPO and listing 19 Oct 2026
Latham & Watkins Advises Latin American Development Bank Corporación Andina de Fomento in US$2 Billion Bond Financing 19 Oct 2026
Linklaters advises on CIG Shanghai’s concurrent new H-share placing and convertible bond offering 19 Oct 2026
Mayer Brown advises The Smarter Web Company on first-of-its-kind UK preferred share offering 15 Oct 2026
Latham & Watkins Advises Bending Spoons on US$330 Million Investment From Berkshire Hathaway 15 Oct 2026
Latham Advises on Cipher Digital’s US$850 Million Convertible Senior Notes Offering and Concurrent Notes Exchange 15 Oct 2026